Endoscopic submucosal dissection

John T. Maple, Barham K. Abu Dayyeh, Shailendra S. Chauhan, Joo Ha Hwang, Sri Komanduri, Michael Manfredi, Vani Konda, Faris M. Murad, Uzma D. Siddiqui, Subhas Banerjee

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

ESD is an established effective treatment modality for premalignant and early-stage malignant lesions of the stomach, esophagus, and colorectum. Compared with EMR, ESD is generally associated with higher rates of en bloc, R0, and curative resections and a lower rate of local recurrence. Oncologic outcomes with ESD compare favorably with competing surgical interventions, and ESD also serves as an excellent T-staging tool to identify noncurative resections that will require further treatment. ESD is technically demanding and has a higher rate of adverse events than most endoscopic procedures including EMR. As such, sufficient training is critical to ensure safe conduct and high-quality resections. A standardized training model for Western endoscopists has not been clearly established, but will be self-directed and include courses, animal model training, and optimally an observership at an expert center. Numerous dedicated ESD devices are now available in the United States from different manufacturers. Although the use of ESD in the United States is increasing, issues related to technical difficulty, limited training opportunities and mentors, risk of adverse events, long procedure duration, and suboptimal reimbursement may limit ESD adoption in the United States to a modest number of academic referral centers for the foreseeable future.

Original languageEnglish (US)
Pages (from-to)1311-1325
Number of pages15
JournalGastrointestinal Endoscopy
Volume81
Issue number6
DOIs
StatePublished - Jun 1 2015
Externally publishedYes

Fingerprint

Mentors
Esophagus
Stomach
Referral and Consultation
Animal Models
Recurrence
Equipment and Supplies
Therapeutics
Endoscopic Mucosal Resection

ASJC Scopus subject areas

  • Gastroenterology
  • Radiology Nuclear Medicine and imaging

Cite this

Maple, J. T., Abu Dayyeh, B. K., Chauhan, S. S., Hwang, J. H., Komanduri, S., Manfredi, M., ... Banerjee, S. (2015). Endoscopic submucosal dissection. Gastrointestinal Endoscopy, 81(6), 1311-1325. https://doi.org/10.1016/j.gie.2014.12.010

Endoscopic submucosal dissection. / Maple, John T.; Abu Dayyeh, Barham K.; Chauhan, Shailendra S.; Hwang, Joo Ha; Komanduri, Sri; Manfredi, Michael; Konda, Vani; Murad, Faris M.; Siddiqui, Uzma D.; Banerjee, Subhas.

In: Gastrointestinal Endoscopy, Vol. 81, No. 6, 01.06.2015, p. 1311-1325.

Research output: Contribution to journalArticle

Maple, JT, Abu Dayyeh, BK, Chauhan, SS, Hwang, JH, Komanduri, S, Manfredi, M, Konda, V, Murad, FM, Siddiqui, UD & Banerjee, S 2015, 'Endoscopic submucosal dissection', Gastrointestinal Endoscopy, vol. 81, no. 6, pp. 1311-1325. https://doi.org/10.1016/j.gie.2014.12.010
Maple JT, Abu Dayyeh BK, Chauhan SS, Hwang JH, Komanduri S, Manfredi M et al. Endoscopic submucosal dissection. Gastrointestinal Endoscopy. 2015 Jun 1;81(6):1311-1325. https://doi.org/10.1016/j.gie.2014.12.010
Maple, John T. ; Abu Dayyeh, Barham K. ; Chauhan, Shailendra S. ; Hwang, Joo Ha ; Komanduri, Sri ; Manfredi, Michael ; Konda, Vani ; Murad, Faris M. ; Siddiqui, Uzma D. ; Banerjee, Subhas. / Endoscopic submucosal dissection. In: Gastrointestinal Endoscopy. 2015 ; Vol. 81, No. 6. pp. 1311-1325.
@article{db814c398dbe42318f383e268ffd47a1,
title = "Endoscopic submucosal dissection",
abstract = "ESD is an established effective treatment modality for premalignant and early-stage malignant lesions of the stomach, esophagus, and colorectum. Compared with EMR, ESD is generally associated with higher rates of en bloc, R0, and curative resections and a lower rate of local recurrence. Oncologic outcomes with ESD compare favorably with competing surgical interventions, and ESD also serves as an excellent T-staging tool to identify noncurative resections that will require further treatment. ESD is technically demanding and has a higher rate of adverse events than most endoscopic procedures including EMR. As such, sufficient training is critical to ensure safe conduct and high-quality resections. A standardized training model for Western endoscopists has not been clearly established, but will be self-directed and include courses, animal model training, and optimally an observership at an expert center. Numerous dedicated ESD devices are now available in the United States from different manufacturers. Although the use of ESD in the United States is increasing, issues related to technical difficulty, limited training opportunities and mentors, risk of adverse events, long procedure duration, and suboptimal reimbursement may limit ESD adoption in the United States to a modest number of academic referral centers for the foreseeable future.",
author = "Maple, {John T.} and {Abu Dayyeh}, {Barham K.} and Chauhan, {Shailendra S.} and Hwang, {Joo Ha} and Sri Komanduri and Michael Manfredi and Vani Konda and Murad, {Faris M.} and Siddiqui, {Uzma D.} and Subhas Banerjee",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.gie.2014.12.010",
language = "English (US)",
volume = "81",
pages = "1311--1325",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Endoscopic submucosal dissection

AU - Maple, John T.

AU - Abu Dayyeh, Barham K.

AU - Chauhan, Shailendra S.

AU - Hwang, Joo Ha

AU - Komanduri, Sri

AU - Manfredi, Michael

AU - Konda, Vani

AU - Murad, Faris M.

AU - Siddiqui, Uzma D.

AU - Banerjee, Subhas

PY - 2015/6/1

Y1 - 2015/6/1

N2 - ESD is an established effective treatment modality for premalignant and early-stage malignant lesions of the stomach, esophagus, and colorectum. Compared with EMR, ESD is generally associated with higher rates of en bloc, R0, and curative resections and a lower rate of local recurrence. Oncologic outcomes with ESD compare favorably with competing surgical interventions, and ESD also serves as an excellent T-staging tool to identify noncurative resections that will require further treatment. ESD is technically demanding and has a higher rate of adverse events than most endoscopic procedures including EMR. As such, sufficient training is critical to ensure safe conduct and high-quality resections. A standardized training model for Western endoscopists has not been clearly established, but will be self-directed and include courses, animal model training, and optimally an observership at an expert center. Numerous dedicated ESD devices are now available in the United States from different manufacturers. Although the use of ESD in the United States is increasing, issues related to technical difficulty, limited training opportunities and mentors, risk of adverse events, long procedure duration, and suboptimal reimbursement may limit ESD adoption in the United States to a modest number of academic referral centers for the foreseeable future.

AB - ESD is an established effective treatment modality for premalignant and early-stage malignant lesions of the stomach, esophagus, and colorectum. Compared with EMR, ESD is generally associated with higher rates of en bloc, R0, and curative resections and a lower rate of local recurrence. Oncologic outcomes with ESD compare favorably with competing surgical interventions, and ESD also serves as an excellent T-staging tool to identify noncurative resections that will require further treatment. ESD is technically demanding and has a higher rate of adverse events than most endoscopic procedures including EMR. As such, sufficient training is critical to ensure safe conduct and high-quality resections. A standardized training model for Western endoscopists has not been clearly established, but will be self-directed and include courses, animal model training, and optimally an observership at an expert center. Numerous dedicated ESD devices are now available in the United States from different manufacturers. Although the use of ESD in the United States is increasing, issues related to technical difficulty, limited training opportunities and mentors, risk of adverse events, long procedure duration, and suboptimal reimbursement may limit ESD adoption in the United States to a modest number of academic referral centers for the foreseeable future.

UR - http://www.scopus.com/inward/record.url?scp=84929606861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929606861&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2014.12.010

DO - 10.1016/j.gie.2014.12.010

M3 - Article

C2 - 25796422

AN - SCOPUS:84929606861

VL - 81

SP - 1311

EP - 1325

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 6

ER -